Voyager Therapeutics COO Executes Routine Sell‑to‑Cover Trade, Maintaining Insider Confidence Amid Volatile Market Conditions
Voyager Therapeutics insider sell‑to‑cover by COO Swartz Robin: routine tax move, no bearish signal—insider confidence stays strong amid partnership and clinical milestones.
3 minutes to read